new glp 1 meds GLP-1 Weight Loss Medication Guide: Wegovy vs Ozempic vs Saxenda Stopping GLP-1 Medications May Raise

Larsen also noted that Marty Makary, M.D., President Donald Trump's pick to lead the FDA, will have "influence over the enforcement of semaglutide compounding and personalization efforts." Makary is an executive at Sesame, another telehealth company that connects consumers with physicians to prescribe compounded weight loss drugs

Patients interested in these options should speak to their GP, who can assess eligibility and refer to appropriate services

Touted as "miracle weight-loss injections", these medications were never meant to be cosmetic fixes alone

Doug Ingram to step down

Further research is necessary to fully validate their therapeutic potentials